Study on prevalence of Metabolic syndrome in Newly detected Type 2 Diabetes Mellitus
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Incidence of Metabolic Syndrome in patients with newly detected Type 2 Diabetes Mellitus
研究概览
简要总结
The greatest majority of patients with type 2 diabetes or impaired glucose tolerance have metabolic syndrome. The presence of metabolic syndrome in these populations relates to a higher prevalence of cardiovascular disease than in patients who have type 2 diabetes or impaired glucose tolerance who do not have the syndrome.
Individuals with metabolic syndrome are twice as likely to die of cardiovascular disease as those who do not, and their risk of an acute myocardial infarction or stroke is threefold higher. With appropriate cardiac rehabilitation and changes in lifestyle the prevalence of syndrome can be reduced.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients giving consent for the study
- •Patients with newly detected type 2 diabetes mellitus 3.Outpatients attending clinics and patients admitted in the hospital.
排除标准
- •1.Pregnancy at diagnosis or gestational diabetes mellitus 2.Secondary diabetes mellitus and other types of diabetes 3.Presence of acute disease that could interfere with glucose metabolism.
结局指标
主要结局
Incidence of Metabolic Syndrome in patients with newly detected Type 2 Diabetes Mellitus
时间窗: 6 months - 1 year
次要结局
- Dyslipidemia & cardiovascular complications in patients with Type 2 Diabetes Mellitus(6 months to 1 year)
研究者
Dr Aayushi Vishvesh Vyas
D.Y.Patil School of Medicine